Skip to main content
Log in

Synthesis and antitumor evaluation ofcis-(1,2-diaminoethane) dichloroplatinum (II) complexes linked to 5- and 6-methyleneuracil and-uridine analogues

  • Research Articles
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

The search for platinum (II)-based compounds with improved therapeutic properties was prompted to design and synthesize a new family of water-soluble, third generation cis-diaminedichloroplatinum (II) complexes linked to uracil and uridine. Six heretofore unreported uracil and uridine-platinum (II) complexes are; [N-(uracil-5-yl-methyl)ethane-1,2-di-amine]dichloroplatinum (II) (3a), [N-(uracil-6-yl-methyl)ethane-1,2-diamine] dichloroplatinum (II) (3b), {[N-(2′,3′,5′-tri-O-acetyl)uridine-5-yl-methyl] ethane-1,2-diamine}dichloroplatinum (II) (6a), {[N-(2′,3′,5′-tri-O-acetyl) uridine-6-yl-methyl]ethane-1,2-diamine}dichloroplatinum (II) (6b), [N-(uridine-5-yl-methyl)ethane-1,2-diamine]dichloroplatinum (II) (7a), [N-(uridine-6-yl- methyl)ethane-1,2-diamine]dichloroplatinum (II) (7b). These analogues were prepared from the key starting materials, 5-chloromethyluracil (1a) and 6-chloromethyluracil (1b) which were reacted with ethylenediamine to afford the respective 5-[(2-aminoethyl)amino] methyluracil (2a) and 6-[(2-aminoethyl)amino]methyluracil (2b). The cis-platin complexes3a and3b were obtained through the reaction of the respective2a and2b with potassium tetrachloroplatiate (II). The heterocyclic nucleic acid bases1a and1b were efficiently introduced on the β-D-ribose ring via a Vorbruggen-type nucleoside coupling procedure with hexamethyldisilazane, trimethylchlorosilane and stannic chloride under anhydrous acetonitrile to yield the stereospecific β-anomeric 5-chloromethyl-2′,3′,5′-tri-O-acetyluridine (4a) and 6-chloromethyl-2′,3′,5′-tri-O-acetyluridine (4b), respectively. The nucleosides4a and4b were coupled with ethylenediamine to provide the respective 5-[(amino-ethyl)amino]methyl-2′,3′,5′-tri-O-acetyluridine (5a) and 6-[(aminoethyl)amino] methyl-2′,3′,5′-tri-O-acetyluridine (5b). The diamino-uridines5a and5b were reacted with potassium tetrachloroplatinate (II) to give the novel nucleoside complexes,6a and6b, respectively which were deacetylated into the free nucleosides,7a and7b by the treatment with CH3ONa. The cytotoxic activities were evaluated against three cell lines (FM-3A, P-388 and J-82) and none of the synthesized compounds showed any significant activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References cited

  • Andrews, P. A. and Howell, S. B., Cellular pharmacology of cisplatin: Perspectives on mechanisms of acquired resistance.Cancer Cell, 2, 35–43 (1990).

    CAS  Google Scholar 

  • Bitha, P., Carvajal, S. G., Citarella, R. V., Child, R. G., DelosSantos, E. F., Dunne, T. S., Durr, F. E., Hlavka, J. J., Lang, Jr, S. A., Lindsay, H. L., Morton, G. O., Thomas, J. P., Wallace, R. E., Lin, Y. L., Haltiwanger, R. C. and Pierpont, C. G.: Water-soluble-third generation antitumor platinum complexes, [2,2-bis (aminomethyl)-1,3-propanediol N,N′]-[1, 1-cyclobutanedicarboxylato(2−)-0,0′][tetrahydro-4H-4,4-dimethanamine-N,N′]platinum (II).J. Med. Chem., 32, 2015–2020 (1989).

    Article  PubMed  CAS  Google Scholar 

  • Burchenal, J. H., Kalahar, K., Dew, K. and Lokys, L., Rationale for development of platinum analogs.Cancer Treat. Rep., 63, 1493–1498 (1979).

    PubMed  CAS  Google Scholar 

  • Carmichael, J., Degraff, W. G., Gazdar, A. F., Minna, J. D. and Mitchel, J. B., Evaluation of tetrazolium based semiautomated colorimetric assay: Assessment of chemo-sensitivity testing.Cancer Res., 47, 936–938 (1987).

    PubMed  CAS  Google Scholar 

  • Harland, S. J., Smith, I. E., Smith, N. and Alison, D. L.,Platinum Coordination Complexes in Cancer Chemotherapy, Hacker, H. P., Douple, E. B. and Krakoff, I. H., Eds; Martius Nihoff Publishing, Boston MA, 1984, p352.

    Google Scholar 

  • Kim, J. C., Dong, E. S., Park, J. I., Bae, S. D. and Kim, S. H., 5-Substituted pyrimidine acyclic nucleoside analogues 1-cyanomethyl- and 1-(4-cyanobutyl)-5-substituted uracil as candidate antitumor agents.Arch. Pharm. Res., 17, 480–482 (1994a).

    Article  PubMed  CAS  Google Scholar 

  • Kim, J. C., Lim, Y. G., Min, B. T. and Park, J. I., Preparation of N′-substitued anilino-N-methyl-N′-nitrosoureas as candidate anititumor agent.Arch. Pharm. Res., 17, 420–423 (1994b).

    Article  PubMed  CAS  Google Scholar 

  • Kim, J. C., Bae, S. S. and Kim, S. H., Synthesis andin vitro cytotoxicity of a homologous series of 9-[ω-N′-methyl-N′-nitrosoureido)alkyl]purine.Korean J. Med. Chem., 4, 66–72 (1994c).

    CAS  Google Scholar 

  • Korolkovas, A.Essentials of Medicinal Chemistry, 2nd. Ed., J. Wiley and Sons: New York, 1988, p875.

    Google Scholar 

  • Mosmann, T., Rapid colorimetric assay for celluar growth and survival: Application to proliferation and cytotoxity assay.J. Immunol. Methods, 65, 55–63 (1983).

    Article  PubMed  CAS  Google Scholar 

  • Nicolini, M., Ed.,Platinum and Other Coordination Compound in Cancer Chemotherapy, Maitinus-Nijhoff Publishing, Boston, 1988.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, J.C., Lee, MH. & Choi, SK. Synthesis and antitumor evaluation ofcis-(1,2-diaminoethane) dichloroplatinum (II) complexes linked to 5- and 6-methyleneuracil and-uridine analogues. Arch. Pharm. Res. 21, 465–469 (1998). https://doi.org/10.1007/BF02974644

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02974644

Key words

Navigation